Literature DB >> 14961048

Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms.

R C Rosen1, S N Seidman, M A Menza, R Shabsigh, S P Roose, L J Tseng, J Orazem, R L Siegel.   

Abstract

Erectile dysfunction (ED) is commonly associated with depressed mood and diminished quality of life (QoL), but few studies have investigated the causal associations involved. Therefore, we evaluated the correlation between several measures of mood, QoL, and sexual function in a retrospective analysis of a sample of depressed men (n=152), with ED enrolled in a clinical trial of sildenafil citrate (VIAGRA). Strong correlations were observed at baseline among measures of erectile function (EF), mood, and overall QoL. Significant treatment effects were observed on all three domains, with significant interactions between changes in mood and QoL. Based on multiple regression and path analysis, a model was developed in which EF changes were associated with improved mood and quality of sexual life, which resulted in improved partner satisfaction, family life, and overall life satisfaction. These data suggest that QoL changes associated with ED therapy may be mediated by changes in sexual function, mood, and family relationships.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961048     DOI: 10.1038/sj.ijir.3901197

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  17 in total

1.  Relationship between erectile function and sexual self-confidence: a path analytic model in men being treated with tadalafil.

Authors:  A Sontag; X Ni; S E Althof; R C Rosen
Journal:  Int J Impot Res       Date:  2013-07-18       Impact factor: 2.896

2.  Treatment expectations of men with ED and their female partners: an exploratory qualitative study based on grounded theory.

Authors:  S Henninger; C Höhn; C Leiber; M M Berner
Journal:  Int J Impot Res       Date:  2015-06-11       Impact factor: 2.896

Review 3.  Impact of Antidepressant Drugs on Sexual Function and Satisfaction.

Authors:  David S Baldwin; Chris Manson; Magda Nowak
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

4.  Depression and sexual dysfunction among HIV-positive and HIV-negative men who have sex with men: mediation by use of antidepressants and recreational stimulants.

Authors:  Trevor A Hart; Brian Mustanski; Daniel T Ryan; Pamina M Gorbach; Ron D Stall; Pamela J Surkan; Michael Plankey
Journal:  Arch Sex Behav       Date:  2014-03-27

5.  Sexual quality of life, body image distress, and psychosocial outcomes in colorectal cancer: a longitudinal study.

Authors:  Jennifer Barsky Reese; Elizabeth Handorf; Jennifer A Haythornthwaite
Journal:  Support Care Cancer       Date:  2018-04-20       Impact factor: 3.603

6.  The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.

Authors:  Angel L Montejo; Laura Montejo; David S Baldwin
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

7.  The effect of testosterone on mood and well-being in men with erectile dysfunction in a randomized, placebo-controlled trial.

Authors:  M Spitzer; S Basaria; T G Travison; M N Davda; L DeRogatis; S Bhasin
Journal:  Andrology       Date:  2013-03-15       Impact factor: 3.842

Review 8.  Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction.

Authors:  Serap Gur; Philip J Kadowitz; Wayne J G Hellstrom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  A multicenter, randomized, open-labeled, parallel group trial of sildenafil in alcohol-associated erectile dysfunction: the impact on psychosocial outcomes.

Authors:  Alexander M Ponizovsky; Lev Averbuch; Ira Radomislensky; Alexander Grinshpoon
Journal:  Int J Environ Res Public Health       Date:  2009-09-23       Impact factor: 3.390

Review 10.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.